Hyundai Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,358,916	476,821	561,851	1,038,982	1,087,244	976,101
Market Cap Growth	139.82%	-15.13%	-45.92%	-4.44%	11.39%	-6.92%
Enterprise Value	1,336,623	447,462	579,143	1,031,571	1,069,527	969,321
Last Close Price	14150.00	4965.00	7055.00	12295.97	12908.41	11895.53
PS Ratio	386.34	135.56	37.33	109.58	138.48	105.62
PB Ratio	12.27	4.31	14.25	22.95	18.67	15.85
P/TBV Ratio	23.21	8.14	89.63	73.68	43.38	34.98
P/FCF Ratio	-	-	269.15	-	-	-
P/OCF Ratio	-	-	248.93	-	-	-
EV/Sales Ratio	-	127.22	38.48	108.80	136.22	104.89
EV/EBITDA Ratio	-	-	394.62	-	-	-
EV/EBIT Ratio	-	-	694.59	-	-	-
EV/FCF Ratio	-73.26	-	277.44	-	-	-
Debt / Equity Ratio	0.16	0.16	0.67	0.12	0.11	0.25
Debt / EBITDA Ratio	-	-	18.12	-	-	-
Debt / FCF Ratio	-	-	12.74	-	-	-
Net Debt / Equity Ratio	-0.20	-0.20	0.58	-0.14	-0.21	-0.11
Net Debt / EBITDA Ratio	1.32	1.32	15.63	0.75	0.51	1.02
Net Debt / FCF Ratio	1.22	1.22	10.99	0.96	0.69	1.57
Asset Turnover	0.04	0.04	0.25	0.16	0.11	0.11
Inventory Turnover	3.18	3.18	1.78	1.62	1.63	1.59
Quick Ratio	2.18	2.18	0.14	1.77	2.23	1.73
Current Ratio	2.25	2.25	0.25	2.18	2.67	2.02
Return on Equity (ROE)	-29.45%	-29.45%	-16.26%	-28.02%	-26.39%	-35.21%
Return on Assets (ROA)	-11.44%	-11.44%	0.86%	-10.20%	-22.24%	-6.66%
Return on Invested Capital (ROIC)	-21.45%	-24.09%	1.65%	-23.13%	-52.30%	-14.85%
Return on Capital Employed (ROCE)	-16.30%	-16.30%	2.10%	-21.40%	-45.10%	-14.70%
Earnings Yield	-1.63%	-4.64%	-1.23%	-1.40%	-1.45%	-2.05%
FCF Yield	-1.34%	-3.83%	0.37%	-0.63%	-1.66%	-0.44%
Buyback Yield / Dilution	-721.14%	-721.14%	-16030.92%	-1.04%	-6.64%	-2.79%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.